Study Reference: Berrocal-Timmons R., Sugaya K., Bane L. D. (2022) “Homologous Use of Allogeneic Umbilical Cord Tissue to Reduce Knee Pain and Improve Knee Function”, Life, Vol. 12(2): 260. (Read Full Study)

Study Overview
This clinical review evaluated 30 patients suffering from chronic knee pain, primarily due to osteoarthritis, who had failed conservative treatments. Each patient received a single injection of cryopreserved allogeneic umbilical cord tissue (UCT) into the knee. Pain levels, functional improvements, and medication use were tracked over a 24-week period.

Key Findings
Pain Reduction: Resting pain scores dropped from approximately 1.95 at baseline to 0.83 at 24 weeks. Pain during activity decreased from 6.28 to 2.87 (p < 0.001).
Improved Function: WOMAC (Western Ontario & McMaster Universities Osteoarthritis Index) scores improved from 44.7 at baseline to 18.5 at 24 weeks (p < 0.001).
Reduced Medication Use: 77.8% of patients reduced or stopped using pain medications, including opioids and NSAIDs, within the 24-week period.
Safety Profile: No significant adverse events related to UCT injections were reported.

Clinical Implications for Generational Health Centers
UCT injections may offer a promising non-surgical option for individuals experiencing chronic knee pain who have not responded to traditional treatments. The results support precision regenerative therapy approaches that focus on the underlying biological contributors to pain, helping patients reduce medication dependence and improve mobility.

Summary
This research suggests that allogeneic umbilical cord tissue injections can significantly reduce knee pain, enhance mobility, and lower medication dependency for up to six months. At Generational Health Centers, these results reflect our mission to deliver advanced, science-based regenerative treatments that help the body heal naturally and restore quality of life.